Penile carcinoma

A single institution experience

Janice Santos-Cortes, Edan Y. Shapiro, Reza Ghavamian

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction. Penile cancer is known to be a rare entity in developed countries with an incidence established to be less than 0.6%. The aim of this study is to describe our experience with penile cancer regarding demographics, clinical data, risk factors and, recurrence. Methods. We retrospectively evaluated our experience in treating penile cancer between 1996 and 2008. Demographic data, associated risks factors, history of circumcision, presence of HPV, and HIV status were documented. Clinical stage at presentation was recorded. Follow-up consisted of clinical and/or radiographic evidence of recurrence. Results. We identified 34 patients who were treated for carcinoma of the penis. Mean patient age was 57 years (32-84). Of the 34 patients, 19 (56%) were Hispanic, 21 (62%) were uncircumcised, 8 (24%) had pathologic evidence of HPV, and 6 (18%) were HIV-positive. A total of 28 patients (82%) were available for follow-up. The majority of the lesions were low-grade (Tis, T1). The treatment goal for low-stage, low-grade tumors was organ preservation. Eight lymphadenectomies were performed. Three patients presented with positive lymphadenopathy. Nine patients (26%) developed a post-operative complication. At a mean of 47 months follow-up, 7 of 28 patients (21%) had clinical and/or radiologic evidence of recurrence. Four of these patients had T1 disease at diagnosis. Conclusion. In our experience, a significant number of patients were found to be HIV-positive as well as having other known risks factors of penile cancer, including evidence of HPV and history of circumcision. The recurrence for T1 disease was high, particularly for patients treated with organ sparing techniques, and several patients were lost to follow-up. Overall, our experience highlights many of the unique characteristics involved in the management of penile cancer.

Original languageEnglish (US)
Pages (from-to)117-120
Number of pages4
JournalCentral European Journal of Urology
Volume63
Issue number3
StatePublished - 2010

Fingerprint

Carcinoma
Penile Neoplasms
Recurrence
HIV
Demography
Human papillomavirus 6
Organ Preservation
Human papillomavirus 18
Lost to Follow-Up
Penis
Lymph Node Excision
Hispanic Americans
Developed Countries
Incidence
Neoplasms

Keywords

  • Penile cancer
  • Penis
  • Treatment

ASJC Scopus subject areas

  • Urology

Cite this

Santos-Cortes, J., Shapiro, E. Y., & Ghavamian, R. (2010). Penile carcinoma: A single institution experience. Central European Journal of Urology, 63(3), 117-120.

Penile carcinoma : A single institution experience. / Santos-Cortes, Janice; Shapiro, Edan Y.; Ghavamian, Reza.

In: Central European Journal of Urology, Vol. 63, No. 3, 2010, p. 117-120.

Research output: Contribution to journalArticle

Santos-Cortes, J, Shapiro, EY & Ghavamian, R 2010, 'Penile carcinoma: A single institution experience', Central European Journal of Urology, vol. 63, no. 3, pp. 117-120.
Santos-Cortes J, Shapiro EY, Ghavamian R. Penile carcinoma: A single institution experience. Central European Journal of Urology. 2010;63(3):117-120.
Santos-Cortes, Janice ; Shapiro, Edan Y. ; Ghavamian, Reza. / Penile carcinoma : A single institution experience. In: Central European Journal of Urology. 2010 ; Vol. 63, No. 3. pp. 117-120.
@article{5cc99fa7fdda4b7286fa4ed757f13a0c,
title = "Penile carcinoma: A single institution experience",
abstract = "Introduction. Penile cancer is known to be a rare entity in developed countries with an incidence established to be less than 0.6{\%}. The aim of this study is to describe our experience with penile cancer regarding demographics, clinical data, risk factors and, recurrence. Methods. We retrospectively evaluated our experience in treating penile cancer between 1996 and 2008. Demographic data, associated risks factors, history of circumcision, presence of HPV, and HIV status were documented. Clinical stage at presentation was recorded. Follow-up consisted of clinical and/or radiographic evidence of recurrence. Results. We identified 34 patients who were treated for carcinoma of the penis. Mean patient age was 57 years (32-84). Of the 34 patients, 19 (56{\%}) were Hispanic, 21 (62{\%}) were uncircumcised, 8 (24{\%}) had pathologic evidence of HPV, and 6 (18{\%}) were HIV-positive. A total of 28 patients (82{\%}) were available for follow-up. The majority of the lesions were low-grade (Tis, T1). The treatment goal for low-stage, low-grade tumors was organ preservation. Eight lymphadenectomies were performed. Three patients presented with positive lymphadenopathy. Nine patients (26{\%}) developed a post-operative complication. At a mean of 47 months follow-up, 7 of 28 patients (21{\%}) had clinical and/or radiologic evidence of recurrence. Four of these patients had T1 disease at diagnosis. Conclusion. In our experience, a significant number of patients were found to be HIV-positive as well as having other known risks factors of penile cancer, including evidence of HPV and history of circumcision. The recurrence for T1 disease was high, particularly for patients treated with organ sparing techniques, and several patients were lost to follow-up. Overall, our experience highlights many of the unique characteristics involved in the management of penile cancer.",
keywords = "Penile cancer, Penis, Treatment",
author = "Janice Santos-Cortes and Shapiro, {Edan Y.} and Reza Ghavamian",
year = "2010",
language = "English (US)",
volume = "63",
pages = "117--120",
journal = "Central European Journal of Urology",
issn = "2080-4806",
publisher = "Panstwowy Zaklad Wydawnictw Lekarskich",
number = "3",

}

TY - JOUR

T1 - Penile carcinoma

T2 - A single institution experience

AU - Santos-Cortes, Janice

AU - Shapiro, Edan Y.

AU - Ghavamian, Reza

PY - 2010

Y1 - 2010

N2 - Introduction. Penile cancer is known to be a rare entity in developed countries with an incidence established to be less than 0.6%. The aim of this study is to describe our experience with penile cancer regarding demographics, clinical data, risk factors and, recurrence. Methods. We retrospectively evaluated our experience in treating penile cancer between 1996 and 2008. Demographic data, associated risks factors, history of circumcision, presence of HPV, and HIV status were documented. Clinical stage at presentation was recorded. Follow-up consisted of clinical and/or radiographic evidence of recurrence. Results. We identified 34 patients who were treated for carcinoma of the penis. Mean patient age was 57 years (32-84). Of the 34 patients, 19 (56%) were Hispanic, 21 (62%) were uncircumcised, 8 (24%) had pathologic evidence of HPV, and 6 (18%) were HIV-positive. A total of 28 patients (82%) were available for follow-up. The majority of the lesions were low-grade (Tis, T1). The treatment goal for low-stage, low-grade tumors was organ preservation. Eight lymphadenectomies were performed. Three patients presented with positive lymphadenopathy. Nine patients (26%) developed a post-operative complication. At a mean of 47 months follow-up, 7 of 28 patients (21%) had clinical and/or radiologic evidence of recurrence. Four of these patients had T1 disease at diagnosis. Conclusion. In our experience, a significant number of patients were found to be HIV-positive as well as having other known risks factors of penile cancer, including evidence of HPV and history of circumcision. The recurrence for T1 disease was high, particularly for patients treated with organ sparing techniques, and several patients were lost to follow-up. Overall, our experience highlights many of the unique characteristics involved in the management of penile cancer.

AB - Introduction. Penile cancer is known to be a rare entity in developed countries with an incidence established to be less than 0.6%. The aim of this study is to describe our experience with penile cancer regarding demographics, clinical data, risk factors and, recurrence. Methods. We retrospectively evaluated our experience in treating penile cancer between 1996 and 2008. Demographic data, associated risks factors, history of circumcision, presence of HPV, and HIV status were documented. Clinical stage at presentation was recorded. Follow-up consisted of clinical and/or radiographic evidence of recurrence. Results. We identified 34 patients who were treated for carcinoma of the penis. Mean patient age was 57 years (32-84). Of the 34 patients, 19 (56%) were Hispanic, 21 (62%) were uncircumcised, 8 (24%) had pathologic evidence of HPV, and 6 (18%) were HIV-positive. A total of 28 patients (82%) were available for follow-up. The majority of the lesions were low-grade (Tis, T1). The treatment goal for low-stage, low-grade tumors was organ preservation. Eight lymphadenectomies were performed. Three patients presented with positive lymphadenopathy. Nine patients (26%) developed a post-operative complication. At a mean of 47 months follow-up, 7 of 28 patients (21%) had clinical and/or radiologic evidence of recurrence. Four of these patients had T1 disease at diagnosis. Conclusion. In our experience, a significant number of patients were found to be HIV-positive as well as having other known risks factors of penile cancer, including evidence of HPV and history of circumcision. The recurrence for T1 disease was high, particularly for patients treated with organ sparing techniques, and several patients were lost to follow-up. Overall, our experience highlights many of the unique characteristics involved in the management of penile cancer.

KW - Penile cancer

KW - Penis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=79960681447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960681447&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 117

EP - 120

JO - Central European Journal of Urology

JF - Central European Journal of Urology

SN - 2080-4806

IS - 3

ER -